The latest gynaecological cancer news
Supporting our neighbours in the Pacific to improve cervical cancer care
Women with cervical cancer in Fiji are receiving treatment in Australia, at Peter Mac, via…
Browsing: Gynaecologic Cancers
Uterine cancer drug gets fast-track approval
A new drug – tulmimetostat – has been given fast-track approval by the US Food and Drug…
New test shows promise for detecting hard-to-find cervical cancers
In findings with potentially important implications for cervical cancer screening, scientists at the National Cancer…
Potential target for reversing drug resistance in ovarian cancer identified
For the 314,000 people diagnosed with ovarian cancer each year, platinum-based drugs such as cisplatin…
Researchers develop novel DNA biosensor for early diagnosis of cervical cancer
Molybdenum disulfide (MoS2) has recently garnered attention among materials science researchers owing to its ability…
Common hormone could hold key to treating endometrial cancer
New research from QIMR Berghofer has found that the hormone testosterone may play an important…
Breast cancer study altered guidelines in Sweden
BRCA1 and BRCA2 are well-known breast cancer genes associated with a significantly increased risk of…
Cancel cervical cancer – In conversation with Brazil, Colombia and Uruguay experts
Despite being highly preventable, the Pan American Health Organization estimates cervical cancer kills 35,700 women…
Oestrogen receptor mutation study suggests potential treatments for endometrial cancers
Researchers at Huntsman Cancer Institute (USA) identified potential new treatment options for people with endometrial cancer.…
FDA approves dostarlimab-gxly with chemotherapy for endometrial cancer
The Food and Drug Administration approved dostarlimab-gxly with carboplatin and paclitaxel, followed by single-agent dostarlimab-gxly, for…